Company intelligence / Profile preview

PT Emjebe Pharma

Pasuruan Regency / Surabaya area [4][9], East Java, Indonesiamjbpharma.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

PT Emjebe Pharma is a growing Indonesian pharmaceutical company specializing in the production of intravenous solutions. The company has expanded its manufacturing capacity, achieved ISO 9000–2015 & Halal certification, exports to several countries including Timor Leste and Cambodia, and provides essential medicines during disasters. No clinical trial data is reported as the focus is on established generic products.[1][2]

Therapeutic areas: Other
Modalities: IV solutions (intravenous fluids)Small molecule drugs (therapeutic drugs for low-end market)[8]
Industry: Contract Manufacturing Organization

Partnerships

No major international pharma partnerships publicly listed; key business relationships include export/import with companies such as Medicap Healthcare Ltd., Hongkong Anjeson Int L Logistic Limited.[5]

Beyond the preview

Go deeper on PT Emjebe Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PT Emjebe Pharma.

Explore the full profile